People: Concert Pharmaceuticals Inc (CNCE.OQ)

CNCE.OQ on NASDAQ Stock Exchange Global Market

11:00pm IST
Change (% chg)

$-0.39 (-4.08%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Auchincloss, Thomas 

Mr. Thomas G. Auchincloss Jr. serves as Independent Director of the Company. Mr. Auchincloss has served as a member of our Board since December 2014. Since September 2013, Mr. Auchincloss has served as Managing Member at Counterpoint Trading Company, LLC, a private investment firm. From August 2007 to September 2013, Mr. Auchincloss was self-employed in private investing. From May 2005 to August 2007, Mr. Auchincloss worked as Chief Financial Officer of Metabolix, Inc., a public biomaterials company. Prior to that, Mr. Auchincloss served as a consultant with Metabolix from April 2002 to May 2005, providing business development, financial and strategic consulting services. From 1994 to 2001, Mr. Auchincloss served in a variety of positions at Vertex Pharmaceuticals Incorporated, a pharmaceutical company, most recently as Vice President, Finance and Treasurer. Mr. Auchincloss received a B.S. in Business Administration from Babson College and an M.B.A. in Finance from the Wharton School. We believe that Mr. Auchincloss’ financial and industry experience, including his experience as the chief financial officer of a publicly traded biomaterials company, make him a key contributor to our Board.

Basic Compensation

Total Annual Compensation, USD 57,733
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 74,074
Fiscal Year Total, USD 131,807

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Aldrich


Roger Tung


Marc Becker


Nancy Stuart


James Cassella


Jeffrey Munsie

As Of  31 Dec 2019